What is Jupiter Neurosciences, Inc. Common Stock?
, a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.63M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.